Akèy › Kasinòm selil renn metastatik ak selil klè › Nebraska › Omaha
Etid klinik pou Kasinòm selil renn metastatik ak selil klè nan Omaha, NE
3 etid pou Kasinòm selil renn metastatik ak selil klè ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
- NEO-811 Omaha Site, Omaha
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 3
- Research Site, Omaha
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Ap rekriteFaz 3
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Oncology Associates PC, Omaha
Etid Kasinòm selil renn metastatik ak selil klè nan lòt vil
- Baldwin Park, CA7 etid
- New York City, NY5 etid
- Dallas, TX5 etid
- Nashville, TN5 etid
- Rochester, MN4 etid
- Waukegan, IL4 etid
- Cleveland, OH4 etid
- St. Louis, MO4 etid
- Ann Arbor, MI3 etid
- San Francisco, CA3 etid
- San Diego, CA3 etid
- Houston, TX3 etid
Lòt etid nan Omaha
- Kansè pwostat27 etid
- Kansè Poumon ki pa ti selil24 etid
- Kansè nan tete22 etid
- Kansè (tout kalite)18 etid
- Kansè kolorektal18 etid
- Myelom Miltip16 etid
- Kansè ovè14 etid
- Limfòm Non-Hodgkin14 etid
- Kansè pankreyas14 etid
- Kansè Metastatik13 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.